With a robust background in finance and entrepreneurial ventures, Jonathan Kolle has established himself as an influential figure in the investment landscape. His experience spans various sectors where he has effectively leveraged market trends to drive business growth. As a founder of multiple successful startups, he demonstrates a keen acumen for identifying emerging opportunities and developing innovative solutions that resonate with consumers. Jonathan's deep understanding of capital markets complements his role as an investor-operator, fostering collaboration between teams while steering companies towards strategic success. His reputation for driving operational excellence makes him a valuable asset within both private enterprises and broader financial contexts.
With a robust background in finance and entrepreneurial ventures, Jonathan Kolle has established himself as an influential figure in the investment landscape. His experience spans various sectors where he has effectively leveraged market trends to drive business growth. As a founder of multiple successful startups, he demonstrates a keen acumen for identifying emerging opportunities and developing innovative solutions that resonate with consumers. Jonathan's deep understanding of capital markets complements his role as an investor-operator, fostering collaboration between teams while steering companies towards strategic success. His reputation for driving operational excellence makes him a valuable asset within both private enterprises and broader financial contexts.
With a keen focus on innovation and market dynamics, Jonathan Kolle seeks out transformative opportunities that align with evolving consumer needs. His entrepreneurial journey, underscored by a series of successful startups, equips him with unique insights into driving sustainable growth. A strong advocate for leveraging technology to optimize operational processes, he strategically positions investments to capitalize on competitive advantages in various sectors. By fostering collaborative environments among his teams, he enhances execution efficacy while navigating the complexities of capital deployment in fast-paced markets.
With a keen focus on innovation and market dynamics, Jonathan Kolle seeks out transformative opportunities that align with evolving consumer needs. His entrepreneurial journey, underscored by a series of successful startups, equips him with unique insights into driving sustainable growth. A strong advocate for leveraging technology to optimize operational processes, he strategically positions investments to capitalize on competitive advantages in various sectors. By fostering collaborative environments among his teams, he enhances execution efficacy while navigating the complexities of capital deployment in fast-paced markets.
| Trades 46 | Longs Won 24/46 52% | Profit Factor 14.39 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $9.11M |
| Average Win $10.31M | Best Trade (Oct 15) $34.57M | Sharpe Ratio 0 |
| Average Loss -$781,728.9 | Worst Trade (Oct 15) -$8.71M | Z-Score 0.16 (12.9%) |
| Commissions $0 | Avg. Trade Length 26y 9m 3w 4d | Expectancy $5.01M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.9% |
| Consecutive Losing Trades | 480 | 432 | 384 | 336 | 288 | 240 | 192 | 144 | 96 | 48 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 0019 001957109 | 7,264 | $369,000 | $369,000 | - | - | - | 0.0 |
| 0266 026609107 | 9,000 | $353,000 | $353,000 | - | - | - | 0.0 |
| 0778 077853109 | 6,800 | $419,000 | $419,000 | - | - | - | 0.0 |
| 1667 166751107 | 4,472 | $387,000 | $387,000 | - | - | - | 0.0 |
| 4418 441815107 | 15,300 | $570,000 | $570,000 | - | - | - | 0.0 |
| 7414 741477103 | 90,700 | $3.35M | $3.35M | - | - | - | 0.0 |
| ABS ABS | 33,450 | $1.08M | $1.08M | - | - | - | 0.0 |
ABT Abbott Laboratories | 173,055.19 | $2.82M | $17.82M | - | $15M | 531.68% | +0.351% |
| ADCT ADCT | 40,650 | $2.95M | $2.95M | - | - | - | 0.0 |
AIG American International Group Inc. | 4,340.85 | $5.54M | $337,067 | - | -$5.2M | -93.91% | 0.0 |
AMGN Amgen Inc. | 4,000 | $240,000 | $1.65M | - | $1.41M | 588.07% | 0.0 |
AVY Avery Dennison Corporation | 65,550 | $4.78M | $11.19M | - | $6.41M | 134.26% | 0.0 |
BMY Bristol-Myers Squibb Company | 8,355.45 | $509,999.96 | $473,503.35 | - | -$36,496.61 | -7.16% | 0.0 |
BP BP p.l.c. Sponsored ADR | 73,242 | $4.34M | $3.55M | - | -$789,565.74 | -18.18% | 0.0 |
C Citigroup Inc. | 1,331.27 | $556,003.7 | $165,782.69 | - | -$390,221.01 | -70.18% | 0.0 |
CL Colgate-Palmolive Company | 9,200 | $299,000 | $827,540 | - | $528,540 | 176.77% | 0.0 |
CSCO Cisco Systems, Inc. | 133,600 | $7.16M | $15.37M | - | $8.22M | 114.83% | 0.0 |
| CTX CTX | 58,950 | $1.46M | $1.46M | - | - | - | 0.0 |
DD DuPont de Nemours, Inc. | 32,144.88 | $2.56M | $4.16M | - | $1.6M | 62.5% | 0.0 |
GAP Gap Inc. | 89,235 | $4.11M | $2.04M | - | -$2.07M | -50.37% | 0.0 |